Abstract
The purpose of this study was to develop an injectable in situ liquid crystal formulation for intra-articular (IA) administration, and in situ forming a viscous liquid crystalline gel with long-term release of sinomenine hydrochloride (SMH) upon water absorption. The pseudo-ternary phase diagram of phytantriol (PT)-ethanol (ET)-water was constructed, and isotropic solutions were chosen for further optimization. The physicochemical properties of isotropic solutions were evaluated, and the phase structures of liquid crystalline gels formed by isotropic solutions in excess water were confirmed by crossed polarized light microscopy (CPLM) and small-angle X-ray scattering (SAXS). In vitro drug release studies were conducted by using a dialysis membrane diffusion method. The optimal in situ cubic liquid crystal (ISV2) (PT/ET/water, 64:16:20, w/w/w) loaded with 6 mg/g of SMH showed a suitable pH, showed to be injectable, and formed a cubic liquid crystalline gel in situ with minimum water absorption within the shortest time. The optimal ISV2 was able to sustain the drug release for 6 days. An in situ hexagonal liquid crystal (ISH2) system was prepared by addition of 5% vitamin E acetate (VitEA) into PT in the optimal ISV2 system to improve the sustained release of SMH. This ISH2 (PT/VitEA/ET/water, 60.8:3.2:16:20, w/w/w/w) was an injectable isotropic solution with a suitable pH range. The developed ISH2 was found to be able to sustain the drug release for more than 10 days and was suitable for IA injection for the treatment of rheumatoid arthritis (RA).
Similar content being viewed by others
REFERENCES
Gordon DA, Hastings DE. Clinical features of rheumatoid arthritis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 3rd ed. New York: Mosby; 2003. p. 765–80.
Tarner IH, Müller-Ladner U. Drug delivery systems for the treatment of rheumatoid arthritis. Expert Opin Drug Deliv. 2008;5(9):1027–37.
Pugner KM, Scott DI, Holmes JW, Hieke K. The costs of rheumatoid arthritis: an international long-term view. Semin Arthritis Rheum. 2000;29:305–20.
Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum. 2006;36(3):182–8.
Liu L, Buchner E, Beitze D, Schmidt-Weber CB, Kaever V, Emmrich F, et al. Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine. Int J Immunopharmacol. 1996;18(10):529–43.
Xu M, Liu L, Qi C, Deng B, Cai X. Sinomenine versus NSAIDs for the treatment of rheumatoid arthritis: a systematic review and meta-analysis. Planta Med. 2008;74(12):1423–9.
Qian SS, Chen YL, Gui SY, Wang J, Zhou YJ, Chen L. Enhanced penetration of sinomenine fomulations following skin pretreatment with a polymer microneedle patch. Lat Am J Pharm. 2014;33(3):464–9.
Gerwin N, Hops C, Lucke A. Intraarticular drug delivery in osteoarthritis. Adv Drug Deliv Rev. 2006;58:226–42.
Larsen C, Ostergaard J, Larsen SW, Jensen H, Jacobsen S, Lindegaard C, et al. Intra-articular depot formulation principles: role in the management of postoperative pain and arthritic disorders. J Pharm Sci. 2008;97(11):4622–54.
Lee KW, Nguyen TH, Hanley T, Boyd BJ. Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs. Int J Pharm. 2009;365(1–2):190–9.
Shah JC, Sadhale Y, Chilukuri DM. Cubic phase gels as drug delivery systems. Adv Drug Deliv Rev. 2001;47(2–3):229–50.
Chen YL, Ma P, Gui SY. Cubic and hexagonal liquid crystals as drug delivery systems. Bio Med Res Int. 2014. doi:10.1155/2014/815981.
Clogston J, Caffrey M. Controlling release from the lipidic cubic phase. Amino acids, peptides, proteins and nucleic acids. J Control Release. 2005;107(1):97–111.
Mezzenga R, Schurtenberger P, Burbidge A, Michel M. Understanding foods as soft materials. Nat Mater. 2005;4(10):729–40.
Ubbink J, Burbidge A, Mezzenga R. Food structure and functionality: a soft matter perspective. Soft Matter. 2008;4(8):1569–81.
Mohammady SZ, Pouzot M, Mezzenga R. Oleoylethanolamide-based lyotropic liquid crystals as vehicles for delivery of amino acids in aqueous environment. Biophys J. 2009;96(4):1537–46.
Barauskas J, Landh T. Phase behavior of the phytantriol/water system. Langmuir. 2003;19(23):9562–5.
Wagner E. Panthenol and phytantriol in cosmetics. Parfümerie Kosmetic. 1994;75(4):260–7.
Dong Y, Larson I, Hanley T, Boyd BJ. Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal structure. Langmuir. 2006;22(23):9512–8.
Barauskas J, Johnsson M, Tiberg F. Self-assembled lipid superstructures: beyond vesicles and liposomes. Nano Lett. 2005;5(8):1615–9.
Chang CM, Bodmeier R. Low viscosity monoglyceride-based drug delivery systems transforming into a highly viscous cubic phase. Int J Pharm. 1998;173(1–2):51–60.
Borgheti-Cardoso LN, Depieri LV, Diniz H, Calzzani RA, Fantini MC, Lyomasa MM, et al. Self-assembling gelling formulation based on a crystalline-phase liquid as a non-viral vector for siRNA delivery. Eur J Pharm Sci. 2014;58(16):72–82.
Carvalho FC, Campos ML, Peccinini RG, Gremião MP. Nasal administration of liquid crystal precursor mucoadhesive vehicle as an alternative antiretroviral therapy. Eur J Pharm Biopharm. 2013;84(1):219–27.
Phelps J, Bentley MV, Lopes LB. In situ gelling hexagonal phases for sustained release of an anti-addiction drug. Colloids Surf B: Biointerfaces. 2011;87(2):391–8.
Han K, Pan X, Chen M, Wang R, Xu Y, Feng M, et al. Phytantriol-based inverted type bicontinuous cubic phase for vascular embolization and drug sustained release. Eur J Pharm Sci. 2010;41(5):692–9.
Ahmed AR, Dashevsky A, Bodmeier R. Drug release from and sterilization of in situ cubic phase forming monoglyceride drug delivery systems. Eur J Pharm Biopharm. 2010;75(3):375–80.
Réeff J, Gaignaux A, Goole J, De Vriese C, Amighi K. New sustained-release intraarticular gel formulations based on monolein for local treatment of arthritic diseases. Drug Dev Ind Pharm. 2013;39(11):1731–41.
Ghosh AK, Jasti BR. Parenteral routes of delivery. In: Theory and practice of contemporary pharmaceutics. 1st ed. USA: CRC Press; 2004. p. 387–423.
Yuan Y, Cui Y, Zhang L, Zhu H, Guo Y, Zhong B, et al. Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide. Int J Pharm. 2012;430(1–2):114–9.
Shah VP, Tsong Y, Sathe P, Liu JP. In vitro dissolution profile comparison-statistics and analysis of the similarity factor f 2 . Pharm Res. 1998;15:889–96.
Polli JE, Rekhi GS, Augsburger LL, Shah VP. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J Pharm Sci. 1997;86(6):690–700.
Wadsten-Hindrichsen P, Bender J, Unga J, Engstrom S. Aqueous self-assembly of phytantriol in ternary systems: effect of monoolein, distearoylphosphatidylglycerol and three water-miscible solvents. J Colloid Interface Sci. 2007;315(2):701–13.
Israelachvili J. The science and applications of emulsions-an overview. Colloid Surf A Physicochem Eng Asp. 1994;91(3):1–8.
Engström S, Engström L. Phase behaviour of the lidocaine-monoolein-water system. Int J Pharm. 1992;79(1–3):113–22.
Neustadt DH. Intra-articular injections for osteoarthritis of the knee. Cleve Clin J Med. 2006;73(10):897–911.
Réeff J, Gaignaux A, Goole J, Siepmann J, Siepmann F, Jerome C, et al. Characterization and optimization of GMO-based gels with long term release for intraarticular administration. Int J Pharm. 2013;451(1–2):95–103.
Fong W, Hanley T, Boyd BJ. Stimuli responsive liquid crystals provide ‘on-demand’ drug delivery in vitro and in vivo. J Control Release. 2009;135(3):218–26.
Chang CM, Bodmeier R. Swelling of and drug release from monoglyceride-based drug delivery systems. Int J Pharm. 1997;147(2):135–42.
Lara MG, Bentley MV, Collett JH. In vitro drug release mechanism and drug loading studies of cubic phase gels. Int J Pharm. 2005;293(1–2):241–50.
Geraghty PB, Attwood D, Collett JH, Dandiker Y. The in vitro release of some antimuscarinic drugs from monoolein/water lyotropic liquid crystalline gels. Pharm Res. 1996;13(8):1265–71.
Phan S, Fong WK, Kirby N, Hanley T, Boyd BJ. Evaluating the link between self-assembled mesophase structure and drug release. Int J Pharm. 2011;421(1):176–82.
Rizwan SB, Hanley T, Boyd BJ, Rades T, Hook S. Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: characterisation, swelling and release kinetics. J Pharm Sci. 2009;98(11):4191–204.
ACKNOWLEDGMENTS
The authors are supported by National Natural Science Foundation of China (No. 81274099), Anhui Provincial Natural Science Foundation (No. 1408085QH183), Anhui Provincial Natural Science Foundation (No. 11040606 M219), Natural Science Foundation of the Anhui Higher Education Institutions of China (No. KJ2012A184), and Anhui Provincial Training Plan for a Thousand of Talents. The content is solely the responsibility of the authors and does not necessarily represent the official views of Anhui University of Chinese Medicine or Hospira Inc.
Conflict of interest
The authors declare that there is no conflict of interests regarding the publication of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, Y., Liang, X., Ma, P. et al. Phytantriol-Based In Situ Liquid Crystals with Long-Term Release for Intra-articular Administration. AAPS PharmSciTech 16, 846–854 (2015). https://doi.org/10.1208/s12249-014-0277-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-014-0277-6